Business Description

Glaukos Corp logo
Glaukos Corp
NAICS : 339112 SIC : 3845
ISIN : US3773221029
Description
Glaukos Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma. It offers iStent, a micro-bypass stent for insertion in conjunction with cataract surgery for the reduction of intraocular pressure in adult patients with mild-to-moderate open-angle glaucoma. Its product pipeline also consists of an iStent SA trabecular micro-bypass system, a two-stent product that is slightly wider than the iStent Inject and uses a different auto-injection inserter designed for use in a standalone procedure.
Name Current Vs Industry Vs History
Cash-To-Debt 0.78
Equity-to-Asset 0.5
Debt-to-Equity 0.8
Debt-to-EBITDA -4.98
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 3.49
Distress
Grey
Safe
Beneish M-Score -2.74
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 71.18
9-Day RSI 58.52
14-Day RSI 51.68
6-1 Month Momentum % 7.21
12-1 Month Momentum % 29.91

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 5.95
Quick Ratio 5.36
Cash Ratio 4.48
Days Inventory 189.36
Days Sales Outstanding 45.03
Days Payable 56.18

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -3.2
Shareholder Yield % -0.03

Financials (Next Earnings Date:2024-02-22 Est.)

FRA:6GJ's 30-Y Financials
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014

Glaukos Corp Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €) 283.599
EPS (TTM) (€) -2.513
Beta -0.11
Volatility % 42.33
14-Day RSI 51.68
14-Day ATR (€) 1.227282
20-Day SMA (€) 57.675
12-1 Month Momentum % 29.91
52-Week Range (€) 38.2 - 74
Shares Outstanding (Mil) 48.8

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Glaukos Corp Filings

Filing Date Document Date Form
No Filing Data

Glaukos Corp Stock Events

Event Date Price(€)
No Event Data

Glaukos Corp Frequently Asked Questions

What is Glaukos Corp(FRA:6GJ)'s stock price today?
The current price of FRA:6GJ is €59.50. The 52 week high of FRA:6GJ is €74.00 and 52 week low is €38.20.
When is next earnings date of Glaukos Corp(FRA:6GJ)?
The next earnings date of Glaukos Corp(FRA:6GJ) is 2024-02-22 Est..
Does Glaukos Corp(FRA:6GJ) pay dividends? If so, how much?
Glaukos Corp(FRA:6GJ) does not pay dividend.

Press Release

Subject Date
No Press Release